Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001853:Bone Marrow / Q000378:metabolism*; D001854:Bone Marrow Cells; D002675:Child, Preschool; D003561:Cytarabine / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D004261:DNA Replication; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005260:Female; D006801:Humans; D007938:Leukemia / Q000378:metabolism; D007945:Leukemia, Lymphoid / Q000378:metabolism*; D007948:Leukemia, Monocytic, Acute / Q000378:metabolism*; D007951:Leukemia, Myeloid / Q000378:metabolism*; D007958:Leukocyte Count; D007962:Leukocytes / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009705:Nucleosides / Q000378:metabolism; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012513:Sarcoma, Experimental / Q000378:metabolism; D014316:Tritium
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D009705:Nucleosides; D012334:RNA, Neoplasm; D003561:Cytarabine; D014316:Tritium